Theodoros Zanos, PhD, Harold Silverman, PhD and Kevin Tracey, MD, and their colleagues were the first to decode specific vagus nerve signals used to communicate immune status and inflammation to the brain, published in Proceedings of the National Academy of Sciences (PNAS).
Sangeeta S. Chavan, PhD, Valentin A. Pavlov, PhD, and Kevin J. Tracey, MD, reviewed the connections between the nervous and immune systems to facilitate development of bioelectronic devices as published in Immunity.
Amrit Chiluwal, MD, Raj K. Narayan, MD, Wayne Chaung, PhD, Neal Mehan, MD, Ping Wang, MD, Chad Bouton, and Chunyan Li, PhD, found that trigeminal nerve stimulation (TNS) resulted in increased cerebral blood flow and oxygen to the brain in mice with a severe traumatic brain injury as published in Scientific Reports.
Christoph Correll, MD, and his team summarized the efficacy of antipsychotic drug combination strategies in adults with schizophrenia as published in JAMA Psychiatry.
Kristina M. Deligiannidis, MD, and colleagues studied a new drug to reduce symptoms in severe postpartum depression (PDD) as published in The Lancet.
Valentin A. Pavlov, PhD, and Fernanda Consolim-Colombo, MD, PhD, from the University of Sao Paulo, Brazil lead a team of colleagues who discovered that the FDA-approved Alzheimer’s drug “galantamine” cut key markers of inflammation – a hallmark of metabolic syndrome – by more than 25% in obesity, leading to reduced insulin resistance as published in JCI Insight.
Harold A. Silverman, PhD, Sangeeta S. Chavan, PhD, and their colleagues standardized an experimental protocol to record signals transmitted in the vagus nerve, expanding our knowledge of the communication of inflammation to the brain, which can be used in the study of bioelectronic medicine and the development of bioelectronic medicine devices as published in Bioelectronic Medicine.
Gerin Rachel Stevens, MD, Daniel W. Ross, MD, along with colleagues reported their results on the impact of a popular pre-heart transplant therapy, the left ventricular assist device (LVAD), on the kidney as published in The Clinical Journal of the American Society of Nephrology.
Our research also reached billions through media coverage in such publications as: